Back to search

Article

Efficacy, Tolerability, and Safety of Erenumab for the Preventive Treatment of Persistent Post-Traumatic Headache attributed to Mild Traumatic Brain Injury: An Open-Label Study.

2020-05-08

Abstract excerpt

<h4>Background: </h4> Calcitonin gene-related peptide (CGRP) has recently been implicated in the pathogenesis of post-traumatic headache (PTH), which raises the prospect for therapeutic use of monoclonal antibodies targeting CGRP or its receptor. Therefore, we decided to assess the efficacy, tolerability, and safety of erenumab for prevention of persistent PTH attributed to mild traumatic brain injury.MethodsA sin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
36a74842-7fc3-5441-89c4-2306ddffe8c5
DOI
10.21203/rs.3.rs-25874/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy, Tolerability, and Safety of Erenumab for the Preventive Treatment of Persistent Post-Traumatic Headache attributed to Mild Traumatic Brain Injury: An Open-Label Study.DOI 10.21203/rs.3.rs-25874/v1
Treatment of Persistent Post-Traumatic Headache with the Anti-CGRP Receptor Antibody Erenumab: A Case ReportSemantic proximity
Phenotype-guided Management of Post-traumatic Headache: An Update on Pathophysiology and Treatment.Semantic proximity
Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity
Hypersensitivity to Calcitonin Gene–Related Peptide in Post‐Traumatic HeadacheSemantic proximity
Persistent post-traumatic headache attributed to mild traumatic brain injury: Deep phenotyping and treatment patterns.Semantic proximity
Post-traumatic headache two to four months after mild traumatic brain injury: A description of phenotypes and treatment patterns.Semantic proximity
Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity
Post-traumatic headache phenotypic characteristics and treatment utilization.Semantic proximity
Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisSemantic proximity
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity
Self-Reported Effects of IncobotulinumtoxinA on Headache with Migraine-like Characteristics in Participants with Traumatic Brain Injury vs. Anomalous Health Incidents Treated at a Single Specialty CenterSemantic proximity
Select a neighboring publication to make it the new centre.